Cargando…

Monocyte chemoattractant protein-1 as a potential marker for patients with sepsis: a systematic review and meta-analysis

OBJECTIVE: To investigate the diagnostic value of monocyte chemoattractant protein-1 (MCP-1) as a biomarker for adult patients with sepsis. METHODS: Related studies on the diagnostic value of MCP-1 in adult patients with sepsis were searched in PubMed, Cochrane Library, Embase, CNKI, CBM, Web of Sci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Zhuo, Li, Chenwei, Yu, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502711/ https://www.ncbi.nlm.nih.gov/pubmed/37720514 http://dx.doi.org/10.3389/fmed.2023.1217784

Ejemplares similares

Identification of Serum Monocyte Chemoattractant Protein-1 and Prolactin as Potential Tumor Markers in Hepatocellular Carcinoma
por: Wang, Who-Whong, et al.
Publicado: (2013)

The Effect of Bariatric Surgery on Circulating Levels of Monocyte Chemoattractant Protein-1: A Systematic Review and Meta-Analysis
por: Jamialahmadi, Tannaz, et al.
Publicado: (2022)

The Potential Role of Monocyte Chemoattractant Protein-1 for Major Depressive Disorder
por: Pae, Chi-Un
Publicado: (2014)

Monocyte Chemoattractant Protein 1 is a Prognostic Marker in ANCA-Associated Small Vessel Vasculitis
por: Ohlsson, Sophie, et al.
Publicado: (2009)

Serum Monocyte Chemoattractant Protein-1 in Pancreatic Cancer
por: Sullivan, Jennifer, et al.
Publicado: (2011)

Role of Monocyte Chemoattractant Protein-1 in Myocardial Infarction
por: Morimoto, Hajime, et al.
Publicado: (2007)

Early plasma monocyte chemoattractant protein 1 predicts the development of sepsis in trauma patients: A prospective observational study
por: Wang, Yuchang, et al.
Publicado: (2018)

Characterisation of urinary monocyte chemoattractant protein 1: Potential biomarker for patients with overactive bladder
por: Farhan, Bilal, et al.
Publicado: (2019)

Monocyte chemoattractant protein-1 in patients with peripheral arterial disease.
por: Petrkova, Jana, et al.
Publicado: (2004)

Urinary Monocyte Chemoattractant Protein-1 in Patients With Alport Syndrome
por: Kashtan, Clifford, et al.
Publicado: (2022)

Monocyte chemoattractant protein 1 as a potential biomarker for immune checkpoint inhibitor‐associated neurotoxicity
por: Möhn, Nora, et al.
Publicado: (2023)

Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1–deficient Mice
por: Lu, Bao, et al.
Publicado: (1998)

Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients
por: Hefler, L, et al.
Publicado: (1999)

Influence of HFE variants and cellular iron on monocyte chemoattractant protein-1
por: Mitchell, Ryan M, et al.
Publicado: (2009)

Association between monocyte chemoattractant protein-1 and blood pressure in smokers
por: Komiyama, Maki, et al.
Publicado: (2017)

Serum monocyte chemoattractant protein-1 is a biomarker in patients with diabetes and periodontitis
por: Radhakrishnan, Preethi, et al.
Publicado: (2014)

Monocyte chemoattractant protein-1: a proinflammatory cytokine elevated in sarcopenic obesity
por: Lim, Jun Pei, et al.
Publicado: (2015)

Circulating levels of monocyte chemoattractant protein‐1 as a potential measure of biological age in mice and frailty in humans
por: Yousefzadeh, Matthew J., et al.
Publicado: (2017)

Monocyte chemoattractant protein-1 promoter polymorphism and plasma levels in alzheimer’s disease
por: Porcellini, Elisa, et al.
Publicado: (2013)

Monocyte chemoattractant protein-1 is not required for liver regeneration after partial hepatectomy
por: Wyler, Stephanie L., et al.
Publicado: (2016)

CCL2/Monocyte Chemoattractant Protein 1 and Parathyroid Hormone Action on Bone
por: Siddiqui, Jawed Akhtar, et al.
Publicado: (2017)

Cerebrospinal fluid monocyte chemoattractant protein 1 correlates with progression of Parkinson’s disease
por: Santaella, Anna, et al.
Publicado: (2020)

Chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) antagonists in asthma: a systematic review and meta-analysis protocol
por: Liu, Wei, et al.
Publicado: (2018)

Diagnostic value of monocyte chemoattractant Protein-1, soluble mannose receptor, Presepsin, and Procalcitonin in critically ill children admitted with suspected sepsis
por: Hassuna, Noha A., et al.
Publicado: (2021)

Plasma Monocyte Chemoattractant Protein-1 Level as a Predictor of the Severity of Community-Acquired Pneumonia
por: Yong, Kok-Khun, et al.
Publicado: (2016)

Monocyte chemoattractant protein-1 contributes to morphine tolerance in rats with cancer-induced bone pain
por: Liu, Lei, et al.
Publicado: (2017)

Exploring the role of monocyte chemoattractant protein-1 in fibroblast-like synovial cells in rheumatoid arthritis
por: Tong, Xiang, et al.
Publicado: (2021)

Potential Role of Monocyte Chemoattractant Protein-1 in Monitoring Disease Progression and Response to Treatment in Overactive Bladder Patients
por: Ghoniem, Gamal, et al.
Publicado: (2020)

Analysis of the Monocyte Chemoattractant Protein 1 -2518 Promoter Polymorphism in Korean Patients with Alopecia Areata
por: Hong, Seok-Beom, et al.
Publicado: (2006)

Monocyte chemoattractant protein 1 expression and proliferation in primary central nervous system lymphoma
por: Takahashi, Yoshinobu, et al.
Publicado: (2017)

The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis
por: Yoshimura, Teizo, et al.
Publicado: (2023)

Monocyte chemoattractant protein-1 affects migration of hippocampal neural progenitors following status epilepticus in rats
por: Hung, Yu-Wen, et al.
Publicado: (2013)

PARK2 Mediates Interleukin 6 and Monocyte Chemoattractant Protein 1 Production by Human Macrophages
por: de Léséleuc, Louis, et al.
Publicado: (2013)

Monocyte Chemoattractant Protein-1 (MCP-1) Regulates Macrophage Cytotoxicity in Abdominal Aortic Aneurysm
por: Wang, Qiwei, et al.
Publicado: (2014)

The therapeutic effect of monocyte chemoattractant protein-1 delivered by an electrospun scaffold for hyperglycemia and nephrotic disorders
por: Yong, Cai, et al.
Publicado: (2014)

Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis
por: Graupera, Isabel, et al.
Publicado: (2016)

Data on early postoperative changes in aqueous monocyte chemoattractant protein-1 levels after phacoemulsification
por: Kawai, Motofumi, et al.
Publicado: (2016)

Role of monocyte chemoattractant protein‐1 in liver fibrosis with transient myeloproliferative disorder in down syndrome
por: Kobayashi, Kenichiro, et al.
Publicado: (2018)

Circulating Monocyte Chemoattractant Protein-1 Levels and Lumbar Bone Mineral Density in Korean Women
por: Lee, Seong-Kyu
Publicado: (2017)

Urinary monocyte chemoattractant protein 1 associated with calcium oxalate crystallization in patients with primary hyperoxaluria
por: Wang, Xiangling, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6khupa540h5niin4gt545hmv74